Figure 3
Reduction in maximal standardised uptake volume after eight cycles of neoadjuvant chemotherapy. Percentage reduction in maximal standardised uptake volume (SUVmax) from baseline after eight cycles of neoadjuvant chemotherapy according to pathological response obtained upon completion of chemotherapy. (a) Reductions in SUVmax after four cycles with docetaxel (Taxotere®) (TAX) followed by four cycles with anthracycline-based fluorouracil, epirubicin and cyclophosphamide (FEC). (b) Reductions in SUVmax after four cycles with FEC followed by four cycles with TAX. Data depict the median, interquartile ranges and total ranges. (a) N/complete = 6, N/partial = 9, N/minor = 16. (b) N N/complete = 7, N/partial = 9, N/minor = 12).